Journal article
Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea
C Barnadas, L Timinao, S Javati, J Iga, E Malau, C Koepfli, LJ Robinson, N Senn, B Kiniboro, L Rare, JC Reeder, PM Siba, PA Zimmerman, H Karunajeewa, TM Davis, I Mueller
Malaria Journal | BMC | Published : 2015
Abstract
Background: Drug resistance remains a major obstacle to malaria treatment and control. It can arise and spread rapidly, and vary substantially even at sub-national level. National malaria programmes require cost-effective and timely ways of characterizing drug-resistance at multiple sites within their countries. Methods: An improved multiplexed post-PCR ligase detection reaction - fluorescent microsphere assay (LDR-FMA) was used to simultaneously determine the presence of mutations in chloroquine resistance transporter (crt), multidrug resistance 1 (mdr1), dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes in Plasmodium falciparum (n = 727) and Plasmodium vivax (n = 574..
View full abstractGrants
Awarded by Fogarty International Center
Funding Acknowledgements
This study was supported by grants from Fogarty International Center (TW007872 and TW007377), and the Australian National Health Medical Research Council (#1010203). The Bill & Melinda Gates Foundation funded the original clinical studies under which the samples were collected. TMD was supported by an NHMRC Practitioner Fellowship (#1058260), IM by an NHMRC Senior Research Fellowship (#1043345), HK by an NHMRC Career Development Fellowship (#1064772) and LJR by an NHMRC Early Career Fellowship (#1016443).